Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Pfizer Zoloft Pediatric Data To Be Presented To House Committee This Week

This article was originally published in The Pink Sheet Daily

Executive Summary

Lilly will meet with the House Energy & Commerce Committee Feb. 12 to discuss Prozac data following the panel's request for unpublished studies.

You may also be interested in...



House Committee Requests Unpublished Pediatric Antidepressant Data

Lilly, GlaxoSmithKline, Pfizer and Wyeth are asked to submit unpublished pediatric antidepressant data to House Committee by Feb. 17. Letter cites FDA review of suicidality data for children on antidepressants.

Antidepressant Warnings On Pediatric Suicide Need Immediate Strengthening, Cmte. Says

A joint FDA advisory committee says suicide risk warnings should be communicated to physicians and consumers while the agency re-analyzes pediatric data from antidepressant manufacturers.

Merck Tax Settlement Could Be Smaller Than GSK’s $3.4 Bil. IRS Deal

A possible settlement between Merck and tax authorities could be significantly smaller than GlaxoSmithKline's recent settlement with the IRS based on the companies' projected liability

Topics

UsernamePublicRestriction

Register

PS058573

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel